Elizabeth A Grammer Ardelyx, Inc. (ARDX) insider trading activity

Elizabeth A Grammer is Officer of ARDELYX, INC.. Currently has a direct ownership of 185,334 shares of ARDX, which is worth approximately $893,309. The most recent transaction as insider was on Nov 20, 2024, when has been sold 7,046 shares (Common Stock) at a price of $4.79 per share, resulting in proceeds of $33,750. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 185K

3.66% 3M change

32.77% 12M change

Total Value Held $893,309

ELIZABETH A GRAMMER Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 20 2024	SELL Open market or private sale	$33,750 $4.79 p/Share	7,046 Reduced 3.66%	185,334 Common Stock
Aug 20 2024	SELL Open market or private sale	$41,541 $5.86 p/Share	7,089 Reduced 3.55%	192,380 Common Stock
May 21 2024	SELL Open market or private sale	$54,099 $7.81 p/Share	6,927 Reduced 3.36%	199,469 Common Stock
May 06 2024	SELL Open market or private sale	$2,523,429 $8.88 p/Share	284,170 Reduced 58.24%	203,760 Common Stock
May 06 2024	BUY Exercise of conversion of derivative security	$411,282 $1.87 p/Share	219,937 Added 31.07%	487,930 Common Stock
May 03 2024	SELL Open market or private sale	$405,000 $9.0 p/Share	45,000 Reduced 14.38%	267,993 Common Stock
Mar 20 2024	SELL Open market or private sale	$664,780 $7.73 p/Share	86,000 Reduced 21.55%	312,993 Common Stock
Feb 20 2024	SELL Open market or private sale	$38,780 $8.75 p/Share	4,432 Reduced 1.1%	398,993 Common Stock
Jan 16 2024	BUY Grant, award, or other acquisition	-	127,750 Added 24.05%	403,425 Common Stock
Dec 11 2023	SELL Open market or private sale	$254,000 $5.08 p/Share	50,000 Reduced 15.35%	275,675 Common Stock
Nov 20 2023	SELL Open market or private sale	$10,394 $4.36 p/Share	2,384 Reduced 0.73%	325,675 Common Stock
Aug 21 2023	SELL Open market or private sale	$8,491 $3.55 p/Share	2,392 Reduced 0.72%	328,059 Common Stock
May 23 2023	SELL Open market or private sale	$8,701 $3.65 p/Share	2,384 Reduced 0.72%	330,451 Common Stock
Feb 21 2023	SELL Open market or private sale	$8,742 $3.0 p/Share	2,914 Reduced 0.88%	329,954 Common Stock
Jan 05 2023	BUY Grant, award, or other acquisition	-	78,000 Added 18.98%	332,868 Common Stock
Nov 22 2022	SELL Open market or private sale	$2,409 $1.94 p/Share	1,242 Reduced 0.48%	254,868 Common Stock
Aug 31 2022	BUY Open market or private purchase	$1,860 $0.62 p/Share	3,000 Added 1.16%	256,110 Common Stock
Aug 22 2022	SELL Open market or private sale	$1,211 $0.98 p/Share	1,236 Reduced 0.49%	253,110 Common Stock
Jun 06 2022	SELL Open market or private sale	$39,534 $0.65 p/Share	60,821 Reduced 19.3%	254,346 Common Stock
May 20 2022	SELL Open market or private sale	$846 $0.67 p/Share	1,263 Reduced 0.4%	315,167 Common Stock
Feb 22 2022	SELL Open market or private sale	$1,024 $0.67 p/Share	1,528 Reduced 0.48%	316,430 Common Stock
Jan 06 2022	BUY Grant, award, or other acquisition	-	42,000 Added 11.67%	317,958 Common Stock
Nov 22 2021	SELL Open market or private sale	$532 $0.99 p/Share	537 Reduced 0.19%	275,958 Common Stock
Nov 12 2021	SELL Open market or private sale	$86,724 $1.12 p/Share	77,432 Reduced 21.88%	276,495 Common Stock
Oct 08 2021	SELL Grant, award, or other acquisition	-	250,000 Reduced 41.4%	353,927 Common Stock

Also insider at

SGMT

Sagimet Biosciences Inc.

Director

EAG